文献速递妇幼与学校卫生卫生政策与健康促进

比利时因呼吸道合胞病毒住院儿童的医疗费用评估:一项回顾性队列研究

Evaluation of the costs of care for pediatric patients hospitalized for RSV: A retrospective cohort study in Belgium.
PubMed 文献 · Vaccine · 2025-03-29

该回顾性队列研究基于比利时16家法语医院2018年1月1日至2019年12月31日的数据,分析2176例3岁以下儿童呼吸道合胞病毒(RSV)相关住院的费用。中位住院日为3.67天,中位医院费用为2924欧元,中位医疗保险费用为2221欧元;住院时间更长、严重诊断相关组、儿童重症监护室入住及无创通气与更高费用相关。

要点

  • 中位住院日3.67天,中位医院费用2924欧元,中位医疗保险费用2221欧元。
  • 61.8%的RSV相关住院为1岁以下儿童,74.1%在一年内再入院。
  • 住院时间更长、严重诊断相关组、儿童重症监护室入住及无创通气与更高费用相关。

核心结论

  • 本研究凸显比利时RSV住院显著且被低估的经济负担,强调需要更好的资源分配以减轻RSV对医疗系统的经济影响。

研究设计与样本

  • 回顾性队列研究,使用比利时16家法语医院2018年1月1日至2019年12月31日的数据,通过ICD-10码识别3岁以下RSV诊断,共分析2176例住院的费用评估。

主要发现

  • 2176例RSV相关住院中,61.8%为1岁以下儿童,74.1%在一年内再入院。
  • 中位住院日为3.67天,中位医院费用为2924欧元,中位医疗保险费用为2221欧元。
  • 与更高费用相关的因素包括住院时间更长、严重诊断相关组类别、儿童重症监护室入住及无创通气使用。
  • 1-2岁儿童的费用通常更低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: This study aimed to evaluate the costs of respiratory-syncytial virus (RSV)-related hospitalizations in children under 3 years old in Belgium for hospitals and health insurance, and to identify factors influencing costs. METHODS: This retrospective cohort study used data from 16 French-speaking hospitals in Belgium, covering January 1, 2018, to December 31, 2019. RSV diagnoses for children under three were identified using International Classification of Diseases-Tenth Revision (ICD-10) codes, resulting in 2176 hospitalizations analyzed for cost assessment. Hospital and health insurance costs were derived from administrative and billing data, adjusted for inflation, and analyzed using descriptive and inferential statistics, including regression models to assess cost factors. RESULTS: Of the 2176 RSV-related hospitalizations, 61.8 % were in children under one year, and 74.1 % had readmissions within a year. The median length of stay (LOS) was 3.67 days, with a median hospital cost of €2924 and a median health insurance cost of €2221 per stay. Factors associated with higher costs included longer LOS, severe diagnosis-related group category, pediatric intensive care unit admission, and non-invasive ventilation use, with costs generally lower for children aged 1-2 years. Based on these data, the annual costs in Belgium associated with RSV hospitalizations in the pre-immunization era are estimated to exceed €26 million from the health insurance perspective and €29 million from the hospital perspective. CONCLUSION: This study highlights the significant and underestimated financial burden of RSV hospitalization in Belgium. This emphasizes the need for better resource allocation to reduce the economic impact of RSV on healthcare systems.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Tilmanne A, Pirson M, Leclercq P, et al. Evaluation of the costs of care for pediatric patients hospitalized for RSV: A retrospective cohort study in Belgium. Vaccine. 2025. PMID: 40158305. doi:10.1016/j.vaccine.2025.127065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。